Use of Human Embryonic Stem Cells in the Treatment of Thrombocytopenia: a Case Series.
Treatment options such as corticosteroids, immunoglobulins medicines, blood or platelet transfusions, or splenectomy are used for thrombocytopenia patients
Use of Human Embryonic Stem Cells in the Treatment of Parkinsons Disease: A Case Report
Parkinson’s disease (PD), a progressive disorder of the central nervous system, affects every 1 in 100 persons, aged around 70 in Europe
Single photon emission tomography imaging in Patients with Lyme Disease Treated with Human Embryonic Stem Cells
The purpose of this study was to evaluate the longitudinal changes in brain perfusion in patients with Lyme disease treated with human embryonic stem cells.
A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy
The first human embryonic stem cell (hESC) line was developed in the late nineties. hESCs are capable of proliferating indefinitely and differentiate into all the three embryonic germ layers.